Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Journal of Ovarian Research

Fig. 1

From: S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin

Fig. 1

S100A10 was upregulated in ovarian cancer tissues with carboplatin resistance, and high S100A10 expression predicted poor prognosis. (a) The expression of S100A10 protein in tumor tissues from patients with carboplatin-sensitive or carboplatin-resistant ovarian cancer by immunohistochemistry analysis and representative staining images are shown. Representative images are shown at × 100 (upper panels) or × 400 (lower panels) magnification. (b) Estimation of progression-free survival and overall survival curves by Kaplan-Meier analysis with log-rank test in 138 ovarian cancer patients according to S100A10 expression

Back to article page